Mirae Asset Global Investments Co., Ltd. Janux Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,286 shares of JANX stock, worth $59,367. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,286
Previous 1,947
17.41%
Holding current value
$59,367
Previous $52,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding JANX
# of Institutions
190Shares Held
57.4MCall Options Held
626KPut Options Held
155K-
Ra Capital Management, L.P. Boston, MA11.2MShares$291 Million6.27% of portfolio
-
Janus Henderson Group PLC London, X04.6MShares$119 Million0.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$94.9 Million0.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.33MShares$86.5 Million4.61% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$60.9 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.08B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...